Douglas Taylor, MD
Neurological Surgery · Jackson, TNNPI 1578983797
Payments from drug & device makers
Across 211 payments — averaging $29.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$2K
- Novartis$940
- UCB, Inc.$375
- Biogen$312
- AstraZeneca$287
- Zimmer Biomet$227
- plus $2K from 31 others
What the payments were for
- Travel & lodging$1,66727%
- Food & beverage$4,51673%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 15 | $1,961 |
| Novartis | 55 | $940 |
| UCB, Inc. | 13 | $375 |
| Biogen | 15 | $312 |
| AstraZeneca | 13 | $287 |
| Zimmer Biomet | 3 | $227 |
| Argenx US, Inc. | 11 | $213 |
| Eisai Inc. | 8 | $155 |
| Amneal Pharmaceuticals LLC | 8 | $148 |
| Medtronic | 1 | $144 |
| AbbVie | 8 | $131 |
| Lundbeck LLC | 8 | $131 |
| Amgen | 7 | $112 |
| Orthofix Medical, Inc. | 1 | $107 |
| SK Life Science, Inc. | 5 | $105 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Boston Scientific | 2 | $64 |
| Neurocrine Biosciences, Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Acadia Pharmaceuticals Inc | 3 | $47 |
| Lilly USA, LLC | 3 | $46 |
| Merz Pharmaceuticals, LLC | 1 | $46 |
| CSL Behring | 2 | $43 |
| Neurelis, Inc. | 2 | $37 |
| Genentech USA, Inc. | 2 | $36 |
| Nevro Corp. | 2 | $34 |
| Sanara Medtech Inc. | 1 | $33 |
| Insightec,inc | 2 | $29 |
| Abbott | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Kerecis Limited | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Adamas Pharmaceuticals, Inc. | 1 | $19 |
| Bristol Myers Squibb | 1 | $19 |
| EMD Serono, Inc. | 1 | $14 |
| Upsher-smith Laboratories LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ExcelsiusGPS Robotic Navigation System$1,599
- Excelsius - GPS$133
- Sable$133
- ELLIPSE$133
- Hedron$133
- M6-C$107
How this compares
$6,183 in reported general payments places this provider in the 55th percentile of 156 neurological surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 76 | $527 |
| Methylprednisolone | 46 | $389 |
| Gabapentin | 53 | $284 |
| Primidone | 15 | $208 |
| Meloxicam | 46 | $114 |
| Methocarbamol | 14 | $61 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Jackson
- Kevin FoleyMemphis$167.9M
- Arthur UlmNashville$6.1M
- Adam ArthurMemphis$6.1M
- Maurice SmithMemphis$4.4M
- Robert MericleNashville$3.9M
- Brian OshaughnessyNashville$2.1M
- John BrophyMemphis$2M
- Daniel HoitMemphis$1.5M
- Paul ParkMemphis$1.2M
- Robbi FranklinNashville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.